NTRK gene fusion overexpression

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase II: 1 Phase I/II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Bayer Consumer Care AG Commercial
    LAROTRECTINIB SULFATE
    2022-502667-38-00 6 countries 2016 n=41
    Ended

Phase I/II

1 trial
  • Bayer Consumer Care AG Commercial
    LAROTRECTINIB SULFATE
    2022-502668-20-00 9 countries 2017 n=73
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bayer Consumer Care AG Commercial 2 Phase II, Phase I/II 0
← All indication landscapes